BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 4586714)

  • 21. Metabolic changes in the islets of Langerhans in relationship to the onset of diabetes mellitus.
    Taylor KW
    Diabetologia; 1972 Aug; 8(4):236-43. PubMed ID: 4564647
    [No Abstract]   [Full Text] [Related]  

  • 22. Obesity and diabetes mellitus.
    Pfeiffer EF; Laube H
    Adv Metab Disord; 1974; 7(0):243-55. PubMed ID: 4606857
    [No Abstract]   [Full Text] [Related]  

  • 23. Retained capacity of glucose-mediated insulin secretion in patients with type 2 diabetes mellitus inversely correlates with the duration of diabetes.
    Kaku K; Kawasaki F; Kanda Y; Matsuda M
    Diabetes Res Clin Pract; 2004 Jun; 64(3):221-3. PubMed ID: 15126011
    [No Abstract]   [Full Text] [Related]  

  • 24. [Current pathophysiological and clinical aspects of the mode of action of blood glucose lowering sulfonamides].
    Pfeiffer EF
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():477-502. PubMed ID: 4906024
    [No Abstract]   [Full Text] [Related]  

  • 25. The inexhaustible beta cell.
    Vinik AI; Kalk WJ; Botha JL; Jackson WP; Blake KC
    Diabetes; 1976 Jan; 25(1):11-5. PubMed ID: 1107093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of 2-deoxy-D-glucose on insulin-secretory responses to intravenous glucose, glucagon, tolbutamide and arginine in man.
    Goldsmith SJ; Yalow RS; Berson SA
    Diabetes; 1970 Jun; 19(6):453-7. PubMed ID: 4393032
    [No Abstract]   [Full Text] [Related]  

  • 27. [The influence of various sulphonylurea derivatives on the oral glucose-tolerance tests in healthy subjects and obese and maturity-onset diabetics (author's transl)].
    Haupt E; Beyer J; Schöffling K
    Dtsch Med Wochenschr; 1974 Mar; 99(9):385-8. PubMed ID: 4208186
    [No Abstract]   [Full Text] [Related]  

  • 28. [B-cell stimulation in chronic and chronic relapsing pancreatitis].
    Grabner W; Bergner D; Scharrer H; Sommer B; Berg G
    Klin Wochenschr; 1971 Jul; 49(13):765-7. PubMed ID: 4935071
    [No Abstract]   [Full Text] [Related]  

  • 29. [Tolbutamide, glucagon, leucine and arginine tolerance test].
    Hosaka T; Oka Y
    Nihon Rinsho; 1997 Apr; 55 Suppl 2():423-7. PubMed ID: 9172561
    [No Abstract]   [Full Text] [Related]  

  • 30. Offspring of two diabetic parents: differential serum insulin responses to intravenous glucose and tolbutamide.
    Rojas L; Soeldner JS; Gleason RE; Kahn CB; Marble A
    J Clin Endocrinol Metab; 1969 Dec; 29(12):1569-79. PubMed ID: 4899852
    [No Abstract]   [Full Text] [Related]  

  • 31. Low insulin secretion in decompensated liver cirrhosis with diabetes mellitus.
    Sampelean D; Motocu M
    Rom J Intern Med; 1993; 31(4):265-9. PubMed ID: 8148778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between insulin secretion and pancreas morphology in subjects with chronic pancreatitis.
    Zander E; Lorenz D; Ziegler B; Lippert H; Wolff H; Kostmann G; Dorn A; Besch W; Schulz B; Heinzmann B
    Horm Metab Res; 1984 Dec; 16 Suppl 1():149-54. PubMed ID: 6398255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Insulin secretion and glucose tolerance test in patients with acute pancreatitis].
    Liul'ka AN; Sheverdin IuP; Shakhova ON
    Klin Khir (1962); 1982 Nov; (11):67-8. PubMed ID: 6759769
    [No Abstract]   [Full Text] [Related]  

  • 34. Does glucagon stimulation predict oral glucose tolerance in patients after simultaneous pancreas-kidney transplantation?
    Nauck MA; Pfeffer F; Erb M; Müller T; Benz S; Schmiegel W; Hopt U
    Transplantation; 2000 Aug; 70(3):545-7. PubMed ID: 10949203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Characteristics of endocrine disorders in the early stages of the development of chronic experimental pancreatitis].
    Vladimiro VG; Podotykina OI; Zhuravlev AG; Sukhanov LD
    Biull Eksp Biol Med; 1987 Oct; 104(10):420-3. PubMed ID: 3315035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tolbutamide-glucose tolerance text.
    Yamagata S; Oneda A; Anzai M; Toyota T
    Tohoku J Exp Med; 1967 Dec; 93(4):331-8. PubMed ID: 4871000
    [No Abstract]   [Full Text] [Related]  

  • 37. Exaggerated intestinal glucagon and insulin responses in human subjects.
    Vance JE; Stoll RW; Fariss BL; Williams RH
    Metabolism; 1972 May; 21(5):405-12. PubMed ID: 4401389
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of phenformin on glucose-insulin interrelationships.
    Stout RW; Brunzell JD; Bierman EL; Porte D
    Diabetes; 1974 Jul; 23(7):624-30. PubMed ID: 4841569
    [No Abstract]   [Full Text] [Related]  

  • 39. Maximum stimulation of insulin secretion in children with chemical diabetes and obesity.
    Castells S; Avruskin T; Reddy CM; Hashemi SE
    Am J Med Sci; 1976; 271(1):35-9. PubMed ID: 943938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times.
    Stumvoll M; Van Haeften T; Fritsche A; Gerich J
    Diabetes Care; 2001 Apr; 24(4):796-7. PubMed ID: 11315860
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.